CD2 and mixed phenotype acute leukemia: The present study is also consistent with the analysis of Li et al.40, which shows increased expression of CD markers CD1a, CD2, and CD11b in Mixed-phenotype acute leukaemia (MPAL) patients, and they have revealed that these three CD markers are among the CD markers that have the highest expression and have the most changes.